Pretreatment Tumor Immune Microenvironment Predicts Clinical Response and Prognosis of Muscle-Invasive Bladder Cancer in the Neoadjuvant Chemotherapy Setting

0
12
Scientists examined the relationship between the tumor microenvironment and the clinical efficacy of neoadjuvant chemotherapy in patients with cT2-4aN0M0 bladder cancer using multiplex fluorescence immunohistochemistry.
[British Journal of Cancer]
Abstract